| |
| |
|
| Insider
Information: |
Holtzman Steven H |
| Relationship: |
EVP Corporate Developm... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
8,326 |
|
|
Indirect Shares
|
3,945 |
|
|
| Direct
Value |
$1,928,135 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,271 |
|
|
| Total
Value |
$1,928,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infinity Pharmaceuticals Inc |
INFI |
Director |
2012-05-31 |
0 |
2012-05-31 |
3,945 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
EVP Corporate Developm... |
2016-02-23 |
8,326 |
2012-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INFI |
Infinity Pharmaceuticals ... |
CEO |
• • – |
2008-10-27 |
4 |
OE |
$2.04 |
$229,252 |
D/D |
88,742 |
401,256 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
CEO and Assistant Secretary |
• • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
229,820 |
18,729 |
|
- |
|
| INFI |
Infinity Pharmaceuticals ... |
CEO and Assistant Secretary |
• • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
177,364 |
177,364 |
|
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chairman and CEO |
• • – |
2007-09-14 |
4 |
B |
$9.12 |
$45,601 |
D/D |
5,000 |
234,823 |
2.81 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2008-10-27 |
4/A |
OE |
$3.48 |
$115,376 |
D/D |
33,154 |
345,668 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2012-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
257,834 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2012-05-29 |
4 |
S |
$13.00 |
$2,460,939 |
D/D |
(189,303) |
68,531 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2012-05-30 |
4 |
S |
$13.00 |
$142,454 |
D/D |
(10,958) |
57,573 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2012-05-31 |
4 |
S |
$13.01 |
$749,025 |
D/D |
(57,573) |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corp Devel and Strategy |
• – – |
2012-02-01 |
4 |
D |
$121.26 |
$201,049 |
D/D |
(1,658) |
3,501 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corp Devel and Strategy |
• – – |
2012-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
5,159 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
8,660 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2013-02-01 |
4 |
D |
$157.30 |
$263,949 |
D/D |
(1,678) |
6,982 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2013-02-08 |
4 |
D |
$164.44 |
$154,574 |
D/D |
(940) |
8,386 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2013-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
9,326 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2013-09-17 |
4 |
AS |
$238.98 |
$836,669 |
D/D |
(3,501) |
4,885 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,159 |
10,044 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-01 |
4 |
D |
$312.64 |
$616,213 |
D/D |
(1,971) |
8,073 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,705 |
10,778 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-08 |
4 |
D |
$315.54 |
$402,629 |
D/D |
(1,276) |
9,502 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-12 |
4 |
D |
$323.04 |
$326,270 |
D/D |
(1,010) |
10,634 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,142 |
11,644 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-02-18 |
4 |
AS |
$327.90 |
$400,694 |
D/D |
(1,222) |
9,412 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-03-17 |
4 |
AS |
$334.83 |
$408,827 |
D/D |
(1,221) |
8,191 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Corporate Development |
• • – |
2014-04-17 |
4 |
AS |
$291.00 |
$355,311 |
D/D |
(1,221) |
6,970 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
